Floatz logo

Teniposide

Burkitt Lymphoma

Northern Italy Leukemia GroupSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

47 Active assets in the Burkitt Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
AIDS Malignancy Consortium
Phase 4BBB
METHOTREXATE
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB
Cytosin-Arabinosid
AIDS Malignancy Consortium
Phase 4BBB
ETOPOSIDE
AIDS Malignancy Consortium
Phase 4BBB
Inno-206
AIDS Malignancy Consortium
Phase 4BBB

View all 50 →

Same molecule, other indications

Teniposide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Primary CNS Lymphoma (PCNSL)Dormant
BB
Indicative ·
70 / 100
View asset →
acute lymphoblastic leukemiaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →